Top Stocks
U.S. Stock Market Overview
Top Analyst Stocks
Top Smart Score Stocks
Top Insiders Stocks
Popular
Stock Screener
Top Online Growth Stocks
Trending Stocks
Penny Stock Screener
Dividend Investing
Dividend Calculator
Dividend Yield Calculator
Dividend Stocks
Dividend News
Dividend Calendar
ETFs
Top ETFs by AUM
SPY ETF
QQQ ETF
Stock Comparison
Energy Stocks
Oil Stocks
Best Value Stocks
Airline Stocks
Electric Vehicle Stocks
MATANA Stocks
New
Bank Stocks
Compare More Stocks…
Calendars
IPO Calendar
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
Market Holidays
Daily Analyst Ratings
Daily Insider Trading
Research Tools
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Stock Market News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
News
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
My Watchlist
Smart Portfolio
About Us
About TipRanks
Contact Us
Working with TipRanks
Enterprise Solutions
Tools for Trading Platforms
Data for Hedge Funds
Best Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Smart Portfolio
Expert Center
Ideas
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Top ETFs by AUM
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Top Stocks
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
U.S. Markets
Market Movers
Top Experts
Expert Center
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Research Tools
Stock Screener
Stock Comparison
Dividend Calculator
Popular
Top ETFs by AUM
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Comparisons
Stock Comparison
POPULAR COMPARISONS
Energy Stocks
EV Stocks
Crypto News
Dividend Stocks
Smart Portfolio
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Calendars
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
News
Market News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About Us
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing
ASND
Stock Latest News
Press Releases
Ascendis Pharma Announces Full Year 2022 Financial Results and Business Update Conference Call on February 16
1d ago
ASND
Press Releases
Ascendis Pharma Provides Update on Vision 3×3 Strategic Roadmap at 41st Annual J.P. Morgan Healthcare Conference
1M ago
ASND
The Fly
Ascendis Pharma announces online portal open to request access to TransCon PTH
1M ago
ASND
The Fly
Ascendis Pharma price target raised to $177 from $169 at Wells Fargo
1M ago
TAK
ASND
The Fly
Ascendis Pharma to initiate TransCon PTH U.S. expanded access program
2M ago
ASND
Press Releases
Ascendis Pharma to Initiate TransCon™ PTH U.S. Expanded Access Program for Adult Patients with Hypoparathyroidism
2M ago
ASND
Press Releases
Ascendis Pharma to Participate in the 5th Annual Evercore ISI HealthCONx Conference
3M ago
ASND
Market News
Ascendis Pharma’s Growth Hormone Shows Promising Results in China
3M ago
ASND
Press Releases
Ascendis Pharma Submits Marketing Authorisation Application to the European Medicines Agency for TransCon™ PTH in Adult Patients with Hypoparathyroidism
3M ago
ASND
The Fly
BioMarin should rally ‘meaningfully’ after Ascendis data, says Piper Sandler
3M ago
ASND
BMRN
The Fly
Ascendis Pharma announces topline results from ACcomplisH trial
3M ago
ASND
Press Releases
Once-Weekly TransCon™ CNP Achieved Primary Efficacy Objective, with Superiority at 100 µg/kg/week, in Ascendis Pharma’s Phase 2 ACcomplisH Trial of Children with Achondroplasia Aged 2 to 10 Years
3M ago
ASND
The Fly
Society for Immunotherapy of Cancer to hold a meeting
3M ago
LH
BMY
Press Releases
Dose Escalation Data from transcendIT-101, Ascendis Pharma’s Phase 1/2 Trial of TransCon™ TLR7/8 Agonist in Patients with Advanced Solid Tumors, Presented at SITC 2022
3M ago
ASND
The Fly
Ascendis Pharma presents dose-escalation data from transcendIT-101
3M ago
ASND
The Fly
Society for Immunotherapy of Cancer to hold a meeting
3M ago
LH
BMY
Stock Analysis & Ideas
Goldman Sachs Says These 2 Buy-Rated Stocks Have at Least 60% Upside Potential
4M ago
ASND
GOSS
Press Releases
Ascendis Pharma Announces Recommended Phase 2 Dose and Cohort Expansion for transcendIT-101, a Phase 1/2 Clinical Trial of TransCon™ TLR7/8 Agonist in Solid Tumors
4M ago
ASND
Press Releases
Ascendis Pharma Submits TransCon™ PTH New Drug Application to the U.S. FDA for Adult Patients with Hypoparathyroidism
5M ago
ASND
Press Releases
Ascendis Pharma A/S Announces Second Quarter 2022 Financial Results and Business Update Conference Call on August 10
6M ago
ASND
Show More
You need to enable JavaScript to run this app.